Novo Nordisk stock fell Tuesday after Joe Biden and Bernie Sanders slammed the drugmaker and Eli Lilly for high prices of weight-loss drugs.
(Bloomberg) -- Novo Nordisk A/S and Eli Lilly & Co. shares fell Tuesday after US President Joe Biden demanded price cuts on their blockbuster weight loss and diabetes drugs. Most Read from BloombergDemocrats Weigh Mid-July Vote to Formally Tap Biden as NomineePowerful Hurricane Beryl Aims at Jamaica After Grenada StrikeTrump Immunity Ruling Means Any Trial Before Election Unlikely‘Upflation’ Is the New Retail Trend Driving Up Prices for US ConsumersTrump Seeks to Toss NY Felony Conviction After
The S&P 500 wraps up the first half with gains of 14%, representing one of the strongest performances since the late-1990s dot-com bubble.